Publisher's Synopsis
Examining concerns regarding FDA's proposed changes to generic drug labeling: hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 1, 2014.